NEW RARE BLOG IS LIVE! What does it take to drive real innovation in the rare disease space? For Manuela Maronati, it starts with purpose. In this latest edition of RARE, Laura Hulley, Principal Consultant at SciPro, speaks with Manuela Maronati, Global Asset Head for Neuroinflammation and Rare Disease at UCB, about her journey from engineering to biotech leadership, and why culture, collaboration, and patient focus are the real catalysts for change. With most rare diseases still lacking approved treatments, Manuela’s insights shine a light on how we can move faster, work smarter, and lead with heart. Read the blog and watch the full interview for insight into: 🧠 Why culture and connection are key to innovation 🔄 How cross-functional teams accelerate impact 🌍 What the future of rare disease treatment could look like Check out the blog and watch the video now, click the link below! https://lnkd.in/dVX6EVz7 #RareDiseases #RARE #LifeSciencesLeadership #BiotechInnovation
